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OBJECTIVE Maturity onset diabetes of the young type 3 (MODY3) is a consequence
of heterozygous germline mutation in HNF1A. A subtype of hepatocellular
adenoma (HCA) is also caused by biallelic somatic HNF1A mutations (H-HCA), and
rare HCA may be related to MODY3. To better understand a relationship between
the development of MODY3 and HCA, we compared both germline and somatic
spectra of HNF1A mutations.
RESEARCH DESIGN AND METHODS We compared 151 somatic HNF1A mutations
in HCA with 364 germline mutations described in MODY3. We searched for
genotoxic and oxidative stress features in HCA and surrounding liver tissue.
RESULTS A spectrum of HNF1A somatic mutations significantly differed from the
germline changes in MODY3. In HCA, we identified a specific hot spot at codon
206, nonsense and frameshift mutations mainly in the NH2-terminal part, and
almost all amino acid substitutions were restricted to the POU-H domain. The high
frequency of G-to-T tranversions, predominantly found on the nontranscribed DNA
strand, suggested a genotoxic mechanism. However, no features of oxidative stress
were observed in the nontumor liver tissue. Finally, in a few MODY3 patients with
HNF1A germline mutation leading to amino acid substitutions outside the POU-H
domain, we identified a different subtype of HCA either with a gp130 and/or
CTNNB1 activating mutation.
CONCLUSIONS Germline HNF1A mutations could be associated with different
molecular subtypes of HCA. H-HCA showed mutations profoundly inactivating
hepatocyte nuclear factor-1α function; they are associated with a genotoxic
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